Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Obstet Gynecol ; 143(3): 435-439, 2024 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-38207328

RESUMEN

Early pregnancy loss (EPL) is common, but patients face barriers to the most effective medication (mifepristone followed by misoprostol) and procedural (uterine aspiration) management options. This cross-sectional geospatial analysis evaluated access in New Mexico to mifepristone and misoprostol and uterine aspiration in emergency departments (comprehensive) and to uterine aspiration anywhere in a hospital (aspiration) for EPL. Access was defined as a 60-minute car commute. We collected data from hospital key informants and public databases and performed logistical regression to evaluate associations between access and rurality, area deprivation, race, and ethnicity. Thirty-five of 42 (83.3%) hospitals responded between October 2020 and August 2021. Two hospitals (5.7%) provided comprehensive management; 24 (68.6%) provided aspiration. Rural and higher deprivation areas had statistically significantly lower adjusted odds ratios for comprehensive management (0.03-0.07 and 0.3-0.4, respectively) and aspiration (0.03-0.06 and 0.1-0.3, respectively) access. Mifepristone and uterine aspiration implementation would address disparate access to EPL treatment.


Asunto(s)
Aborto Inducido , Aborto Espontáneo , Misoprostol , Embarazo , Femenino , Humanos , Mifepristona/uso terapéutico , Aborto Espontáneo/epidemiología , Aborto Espontáneo/terapia , Misoprostol/uso terapéutico , Estudios Transversales , Aspiración Respiratoria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...